Literature DB >> 82680

Very long-term treatment of peptic ulcer with cimetidine.

J M Cargill, J H Saunders, N Peden, K G Wormsley.   

Abstract

In an open trial, 96 patients with endoscopically proven peptic ulcers were randomly allocated to treatment with cimetidine (1 g/day) for periods of 3, 6, 9, or 12 months. After their courses of treatment, the patients were followed up for at least 6 months. In 92% the ulcers had healed after treatment for 1 month, and in a further 5% the ulcers healed during the next 2 months. Ulcers recurred during treatment in 24% of patients and within 6 months of withdrawal of treatment in a further 43%. In nearly a third of patients the recurrences were asymptomatic and were discovered only through routine endoscopic studies. Continuous treatment with full doses of cimetidine for a year seems to prevent relapse of the majority of ulcers which have healed during treatment; but it does not cure the ulcer disease, since relapse generally occurs quite rapidly when treatment is discontinued.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82680     DOI: 10.1016/s0140-6736(78)92273-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  There is more to healing ulcers than suppressing acid.

Authors:  D G Colin-Jones
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

2.  Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).

Authors:  M J Collen; V J Stanczak; C A Ciarleglio
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

3.  Women and duodenal ulcer.

Authors:  N R Peden; E J Boyd; K G Wormsley
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

Review 4.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

5.  Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders.

Authors:  T Gledhill; M Buck; R H Hunt
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

Review 6.  Drugs for the prevention of peptic ulcer recurrence.

Authors:  D W Piper
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

7.  Bleeding duodenal ulcer. Role of gastric acid hypersecretion.

Authors:  M J Collen; A N Kalloo; M J Sheridan
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

8.  Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study.

Authors:  M G Korman; D J Hetzel; J Hansky; D J Shearman; G Don
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

9.  Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.

Authors:  J C Delchier; F Roudot-Thoraval; L Stanescu; M C Deharvengt; L Elouaer Blanc
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

10.  Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence.

Authors:  A Danielsson; B Ek; L Steen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.